TCRT icon

Alaunos Therapeutics

133 hedge funds and large institutions have $171M invested in Alaunos Therapeutics in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership:

25% less capital invested

Capital invested by funds: $228M → $171M (-$56.5M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

63% less call options, than puts

Call options by funds: $1.39M | Put options by funds: $3.75M

Holders
133
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.39M
Puts
$3.75M
Net Calls
Net Calls Change

Top Sellers

1 -$5.04M
2 -$1.14M
3 -$1M
4
Renaissance Technologies
Renaissance Technologies
New York
-$942K
5
Norges Bank
Norges Bank
Norway
-$816K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$202K
52
$199K
53
$194K
54
$193K
55
$192K
56
$189K
57
$188K
58
$176K
59
$173K
60
$172K
61
$168K
62
$151K
63
$147K
64
$146K
65
$142K
66
$134K
67
$132K
68
$119K
69
$117K
70
$108K
71
$106K
72
$100K
73
$92K
74
$84K
75
$84K